About
Marco is an early-stage venture capitalist with a focus on identifying and nurturing disruptive technology startups. With over two decades of experience in the venture capital landscape, Marco has established himself as a strategic thinker and a trusted advisor to entrepreneurs. Throughout his career, Marco has demonstrated a keen eye for promising investment opportunities across various sectors, including nanotechnology, life sciences, blockchain, artificial intelligence and quantum computing. His ability to identify emerging trends and disruptive technologies has led to successful investments in numerous early-stage companies. Marco's track record speaks for itself, with more than 30 of his investments achieving notable exits through acquisitions or successful IPOs, representing $50 billion of aggregate value creation. Some of those early investments include Arrowhead Pharmaceuticals (Nasdaq: ARWR), NanoGram (sold to Teijin), Arryx, Inc. (sold to Haemonetics).
Position in the VCSift Database
- • 2 investors at Northern Data Group are tracked.
- • 1 investors hold the Founder role in VCSift. Marco Beckmann is one of them.
- • 381 investors are based in Frankfurt, Hessen, Germany.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Frankfurt, Germany
Contact Information
Find more investors like Marco
Search Investors